Dr. Kerry Kaye McGowan, MD
- Publications
- 2
- Clinical trials
- 4
- MIPS score, 2024
- 100
- Hospital affiliations
- 1
- Industry payments
- $2,028
- Practice address
- 231 E Chestnut St, Louisville, KY 40202
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Norton Children's Hospital-Invasive Cardiology - HOPD
Acute Care Hospital outpatient department · Louisville, Kentucky
Find Dr. McGowan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Kerry Kaye McGowan is a pediatric hematology and oncology physician in Louisville, Kentucky
Dr. McGowan practices at Norton Children's Hospital-Invasive Cardiology - HOPD in Louisville, Kentucky.
Dr. McGowan's NPI, 1235331984, was assigned on June 4, 2007. Dr. McGowan holds Kentucky license 46284.
- NPI
- 1235331984NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1951548981
- NPI enumeration date
- June 4, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 48
- Medical school graduation
- 2004
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Kerry Kaye McGowan practices at Norton Children's Hospital-Invasive Cardiology - HOPD in Louisville, Kentucky
Dr. McGowan's primary practice is Norton Children's Hospital-Invasive Cardiology - HOPD, at 231 E Chestnut St, Louisville, KY 40202.
- Norton Children's Hospital-Invasive Cardiology - HOPD231 E Chestnut St, Louisville, KY 40202
Source: Dmand AI Affiliation Data
Dr. Kerry Kaye McGowan is affiliated with 4 sites of care and 2 medical groups
Dr. McGowan's primary practice is Norton Children's Hospital-Invasive Cardiology - HOPD in Louisville, Kentucky. Dr. McGowan is also affiliated with Norton Hospital. The medical group on file is UofL Physicians, Radiology. Dmand AI also links Dr. McGowan to 2 more group practices and clinics and 1 medical group, each named with a free account.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Kerry Kaye McGowan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGowan practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Norton Children's Hospital-Invasive Cardiology - HOPD | Available with a free account |
| +3 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Kerry Kaye McGowan is one of 21 pediatric hematologys and oncology physicians in Kentucky
Pediatric hematology-oncology is Dr. McGowan's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. McGowan is licensed in Kentucky.
Specialties and state licenses
- Pediatric hematology and oncology, KentuckyPrimary
Pediatric hematologys and oncology physicians near Dr. McGowan
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Kerry Kaye McGowan's patients have a median age of 13
Across all payers, Dmand AI patient panel data puts Dr. McGowan's median patient age at 13, with 41% women.
Dr. McGowan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 13
Patient panel by sex, all payers
- Women41%
- Men59%
Source: Dmand AI Patient Panel Data
Dr. Kerry Kaye McGowan scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. McGowan for performance year 2024, reported as part of a group. Dr. McGowan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. McGowan's MIPS scores, performance year 2024
- 100of 100Final score
- 97.1of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 76of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
Dr. Kerry Kaye McGowan has 2 publications on record
Dmand AI links 2 papers to Dr. McGowan, published from 2021 to 2022. Dr. McGowan's most frequent co-authors are Erika B. Chandler, Esther Elise Knapp, MD and Arpita Lakhotia, MD.
Dr. McGowan's most frequent co-authors
- Erika B. Chandler1 shared paper
- Esther Elise Knapp, MD1 shared paper
- Arpita Lakhotia, MD1 shared paper
Recent publications by Dr. McGowan
See who Dr. McGowan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. McGowan works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Kerry Kaye McGowan has worked on 4 clinical trials
Dmand AI links Dr. McGowan to 4 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Neuroblastoma, Postthrombotic Syndrome and Rhabdomyosarcoma, Embryonal. National Cancer Institute (NCI) sponsors the most, 2.
Clinical trials with Dr. McGowan by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 2Phase 3: 2 trials
- NonePhase 4: no trials
Conditions in Dr. McGowan's trials
- Neuroblastoma
- Postthrombotic Syndrome
- Rhabdomyosarcoma, Embryonal
- Sarcoma, Clear Cell
- Neuroectodermal Tumors, Primitive, Peripheral
Investigators on the most trials with Dr. McGowan
- Wendy L. Woods-Swafford, MD3 shared trials
- Roland Lee-Shing Chu, MD2 shared trials
- Jocelyn A. Lewis, DO2 shared trials
Recent clinical trials with Dr. McGowan
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma (opens in a new tab)
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (opens in a new tab)
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma (opens in a new tab)
Evaluation of the Duration of Therapy for Thrombosis in Children (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Kerry Kaye McGowan received $2,028 in industry payments from 2016 to 2025
CMS Open Payments shows 29 general payments to Dr. McGowan from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Jazz Pharmaceuticals Inc. paid the most, $229.
General payments to Dr. McGowan by program year, 2016 to 2025
Companies that paid Dr. McGowan the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Kerry Kaye McGowan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Kerry Kaye McGowan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Kerry Kaye McGowan's NPI number?
Dr. Kerry Kaye McGowan's NPI number is 1235331984. It was assigned on June 4, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Kerry Kaye McGowan?
Dr. Kerry Kaye McGowan is a pediatric hematology and oncology physician in Louisville, Kentucky. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Kerry Kaye McGowan practice?
Dr. McGowan practices at 231 E Chestnut St, Louisville, KY 40202. Dr. McGowan's primary practice is Norton Children's Hospital-Invasive Cardiology - HOPD in Louisville, Kentucky. Dmand AI also links Dr. McGowan to 2 group practices and clinics and 1 medical group.
What is Dr. Kerry Kaye McGowan's medical license number?
Dr. McGowan holds Kentucky license 46284.
Which hospitals is Dr. Kerry Kaye McGowan affiliated with?
Dr. McGowan is affiliated with Norton Hospital.
What medical group is Dr. Kerry Kaye McGowan part of?
Dr. McGowan is linked to UofL Physicians, Radiology. Dmand AI links Dr. McGowan to 1 more medical group.
Does Dr. Kerry Kaye McGowan accept Medicare?
Yes. CMS lists Dr. McGowan as accepting Medicare assignment.
What is Dr. Kerry Kaye McGowan's MIPS score?
Dr. McGowan's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.
Has Dr. Kerry Kaye McGowan received payments from drug or device companies?
CMS Open Payments shows $2,028 in general payments to Dr. McGowan from 17 companies from 2016 to 2025. The largest total came from Jazz Pharmaceuticals Inc.
How long has Dr. Kerry Kaye McGowan been practicing?
Dr. McGowan graduated from medical school in 2004, 22 years ago.
Does Dr. Kerry Kaye McGowan do research?
Dmand AI links 2 publications to Dr. McGowan, published from 2021 to 2022. Dr. McGowan has worked on 4 clinical trials.
Who does Dr. Kerry Kaye McGowan publish with?
Dr. McGowan's most frequent co-authors are Erika B. Chandler (1 shared paper), Esther Elise Knapp, MD (1 shared paper) and Arpita Lakhotia, MD (1 shared paper).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Kentucky by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card